Patents-Review.com
ClassID:

21067 ⎘

A61K39/0013 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine

Recent Application in this class:
#1
20260049057
2026-02-19

OPIOID HAPTENS, CONJUGATES, VACCINES, AND METHODS OF GENERATING ANTIBODIES

 #2
20250361283
2025-11-27

BTNL3 PROTEINS, NUCLEIC ACIDS AND ANTIBODIES AND USES THEREOF

 #3
20250177506
2025-06-05

VACCINATION AND ANTIBODY GENERATION PLATFORM

 #4
20250161423
2025-05-22

SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS

 #5
20250144195
2025-05-08

CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AS ANTI-CANCER THERAPEUTICS

 #6
20250114441
2025-04-10

POLYMERIC VACCINE FOR OPIOID ADDICTION

 #7
20250032607
2025-01-30

LIPID NANOPARTICLE-BASED ANTI-FENTANYL VACCINE

 #8
20240390469
2024-11-28

TARGETED TRADITIONAL CHINESE MEDICINE IN-SITU TUMOR VACCINE, AND PREPARATION METHOD AND APPLICATION THEREOF

 #9
20240316171
2024-09-26

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOTHERAPY

 #10
20240307517
2024-09-19

DEVELOPMENT OF A HIGHLY EFFICIENT SECOND GENERATION FENTANYL-CONJUGATE VACCINE TO TREAT FENTANYL ADDICTION

 #11
20240189417
2024-06-13

SUBSTITUTION OF NUCLEOTIDE BASES IN SELF-AMPLIFYING MESSENGER RIBONUCLEIC ACIDS

 #12
20240115685
2024-04-11

CONJUGATED FUMONISIN TO PROTECT AGAINST MYCOTOXICOSIS

 #13
20240075120
2024-03-07

SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS

 #14
20240024446
2024-01-25

CONJUGATED AFLATOXIN B TO PROTECT AGAINST MYCOTOXICOSIS

 #15
20230338495
2023-10-26

Vaccine Compositions and Antibodies For Lyme Disease

 #16
20230310438
2023-10-05

TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING INDIVIDUALS

 #17
20230201324
2023-06-29

Compositions and Methods for Treating Cocaine, Nicotine, and Methamphetamine Dependence

 #18
20230192802
2023-06-22

BTNL3 PROTEINS, NUCLEIC ACIDS AND ANTIBODIES AND USES THEREOF

 #19
20230190904
2023-06-22

Compositions and Methods for Treating Morphine, Heroin, and Alcohol Dependence

 #20
20230181728
2023-06-15

ADJUVANTED CONJUGATE OPIOID VACCINE

 #21
20230165953
2023-06-01

IMMUNIZATION SCHEME FOR VARIANT SURFACE GLYCOPROTEIN CARRIERS

 #22
20230165947
2023-06-01

CYCLOPHOSPHAMIDE ANALOGS FOR USE AS IMMUNOGENS AND ASSAY CONJUGATES FOR AN IMMUNOASSAY OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE

 #23
20230126276
2023-04-27

FENTANYL HAPTENS, FENTANYL HAPTEN CONJUGATES, AND METHODS FOR MAKING AND USING

 #24
20230100186
2023-03-30

FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE

 #25
20230063876
2023-03-02

Virus-Like Particle Vaccines for Opioid Drugs

 #26
20220409722
2022-12-29

FENTANYL HAPTEN, FENTANYL HAPTEN-CONJUGATES, AND METHODS FOR MAKING AND USING

 #27
20220362375
2022-11-17

Methods of rational nicotine hapten design and uses thereof

 #28
20220362374
2022-11-17

Antibodies Against Fentanyl and Fentanyl Analogs

 #29
20220332770
2022-10-20

High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier

 #30
20220081400
2022-03-17

OPIOID HAPTENS, CONJUGATES, VACCINES, AND METHODS OF GENERATING ANTIBODIES

 #31
20220080042
2022-03-17

6-acetylmorphine analogs, and methods for their synthesis and use

 #32
20220000996
2022-01-06

Chimeric antigen receptor-expressing T cells as anti-cancer therapeutics

 #33
20210401956
2021-12-30

Vsg-based vaccination and antibody generation platform for the treatment of diseases

 #34
20210346482
2021-11-11

SUBSTANCES, VACCINES AND METHODS FOR DIAGNOSING AND REDUCING INCIDENCES OF TRANSPLANT REJECTION

 #35
20210340190
2021-11-04

FLAGELLIN COMPOSITIONS AND USES

 #36
20210269491
2021-09-02

Flagellin-based agents and uses including effective vaccination

 #37
20210268088
2021-09-02

Heroin vaccine

 #38
20210228699
2021-07-29

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOTHERAPY

 #39
20210128720
2021-05-06

Synthetic opioid vaccine

 #40
20210107862
2021-04-15

Methods and compositions for substance use disorder vaccine formulations and uses thereof

 #41
20200392190
2020-12-17

Flagellin-based agents and uses including effective vaccination

 #42
20200390881
2020-12-17

NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE

 #43
20200277339
2020-09-03

Flagellin compositions and uses

 #44
20200115324
2020-04-16

METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF

 #45
20200078453
2020-03-12

METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT

 #46
20200061172
2020-02-27

SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS

 #47
20200016252
2020-01-16

Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide

 #48
20190351037
2019-11-21

Nicotine nanovaccines and uses thereof

 #49
20190315810
2019-10-17

Flagellin-based agents and uses including effective vaccination

 #50
20190240306
2019-08-08

ANTI-OPIOID VACCINES

 #51
20190233478
2019-08-01

Flagellin compositions and uses

 #52
20190169259
2019-06-06

BTNL3 proteins, nucleic acids and antibodies and uses thereof

 #53
20180354995
2018-12-13

FLAGELLIN-BASED AGENTS AND USES INCLUDING EFFECTIVE VACCINATION

 #54
20180353597
2018-12-13

6-ACETYLMORPHINE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE

 #55
20180326031
2018-11-15

Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide

 #56
20180256709
2018-09-13

IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS

 #57
20180251498
2018-09-06

Flagellin compositions and uses

 #58
20180125969
2018-05-10

Methods of rational nicotine hapten design and uses thereof

 #59
20180043023
2018-02-15

DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS

 #60
20180043015
2018-02-15

Methods for diagnosing and reducing incidences of cardiac allograft rejection

 #61
20170296654
2017-10-19

6-acetylmorphine analogs, and methods for their synthesis and use

 #62
20170290900
2017-10-12

CHIMERIC ANTIGEN RECEPTOR-EXPRESSING T CELLS AS ANTI-CANCER THERAPEUTICS

 #63
20170266278
2017-09-21

Flagellin-based agents and uses including effective vaccination

 #64
20170239346
2017-08-24

NOVEL COCAINE HAPTENS AND NANOFIBER-BASED COCAINE VACCINES

 #65
20170079918
2017-03-23

Crosslinked vaccination composition

 #66
20170049883
2017-02-23

Synthetic hapten carrier compositions and methods

 #67
20170014499
2017-01-19

NOVEL TREATMENT METHOD

 #68
20160324958
2016-11-10

Flagellin-containing protein nanoparticles as a vaccine platform

 #69
20160271236
2016-09-22

RECOMBINANT T-CELL RECEPTOR LIGAND FOR THE TREATMENT OF COGNITIVE AND NEUROPSYCHIATRIC IMPAIRMENT INDUCED BY SUBSTANCE ADDICTION

 #70
20160193326
2016-07-07

Vaccine Compositions for Drug Addiction

 #71
20160030541
2016-02-04

Method of modifying the immune response

 #72
20160030348
2016-02-04

Vaccination composition

 #73
20160022809
2016-01-28

6-acetylmorphine analogs, and methods for their synthesis and use

 #74
20160022794
2016-01-28

Siderophore-based immunization against gram-negative bacteria

 #75
20150343042
2015-12-03

Anti-drug vaccines

 #76
20150329520
2015-11-19

Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction

 #77
20150328309
2015-11-19

Dose selection of adjuvanted synthetic nanocarriers

 #78
20150328300
2015-11-19

Immunomodulatory agent-polymeric compounds

 #79
20150166630
2015-06-18

BTNL3 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF

 #80
20150064212
2015-03-05

PROCESS FOR THE PREPARATION AND USE OF A BIVALENT VACCINE AGAINST MORPHINE-HEROIN ADDICTION

 #81
20150056251
2015-02-26

AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation

 #82
20150017201
2015-01-15

NOVEL NICOTINE DNA VACCINES

 #83
20140294869
2014-10-02

Immune tolerance inducer

 #84
20140193453
2014-07-10

Immunomodulatory agent-polymeric compounds

 #85
20140128448
2014-05-08

Nucleic acid/polysaccharide complex

 #86
20140044734
2014-02-13

Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis

 #87
20130189300
2013-07-25

Conjugates comprising an antigen and a carrier molecule

 #88
20130122025
2013-05-16

METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS

 #89
20130089564
2013-04-11

Therapeutic Uses of Glandular Kallikrein

 #90
20130064839
2013-03-14

Method of rapidly producing improved vaccines for animals

 #91
20130011432
2013-01-10

Disrupted adenovirus-based vaccine against drugs of abuse

 #92
20120269828
2012-10-25

Anti-drug vaccines

 #93
20120258130
2012-10-11

VACCINATION REGIMEN FOR B-CELL VACCINES

 #94
20120195921
2012-08-02

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

 #95
20120171239
2012-07-05

Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use

 #96
20120114677
2012-05-10

Modified nicotinic compounds and related methods

 #97
20120087890
2012-04-12

Immunonanotherapeutics that provide IGG humoral response without T-cell antigen

 #98
20120027806
2012-02-02

Dose selection of adjuvanted synthetic nanocarriers

 #99
20110318381
2011-12-29

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

 #100
20110293723
2011-12-01

SYNTHETIC NANOCARRIER COMBINATION VACCINES

 #101
20110293701
2011-12-01

MULTIVALENT SYNTHETIC NANOCARRIER VACCINES

 #102
20110293700
2011-12-01

NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT

 #103
20110229511
2011-09-22

METHOD OF MODIFYING THE IMMUNE RESPONSE

 #104
20110217320
2011-09-08

HAPTEN-CARRIER CONJUGATES FOR TREATING AND PREVENTING NICOTINE ADDICTION

 #105
20110182918
2011-07-28

Personalized drug treatment and smoking cessation kit and method

 #106
20110142874
2011-06-16

Compositions, Methods, and Kits for Eliciting an Immune Response

 #107
20110136209
2011-06-09

PROCESS FOR THE PREPARATION OF NICOTINE-BASED HAPTENS

 #108
20110086063
2011-04-14

VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION

 #109
20110081371
2011-04-07

Angiotensin peptide-carrier conjugates and uses thereof

 #110
20110064750
2011-03-17

METHOD AND KIT FOR TREATING NICOTINE ADDICTION

 #111
20110027217
2011-02-03

Immunomodulatory agent-polymeric compounds

 #112
20110020388
2011-01-27

TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS

 #113
20110002957
2011-01-06

Hapten-carrier conjugates for treating and preventing nicotine addiction

 #114
20100303850
2010-12-02

NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE

 #115
20100209449
2010-08-19

HAPTEN-CARRIER CONJUGATES FOR USE IN DRUG-ABUSE THERAPY AND METHODS FOR PREPARATION OF SAME

 #116
20100183727
2010-07-22

Immunonanotherapeutics that provide IgG humoral response without T-cell antigen

 #117
20100129395
2010-05-27

Hapten-carrier conjugates and uses thereof

 #118
20100119540
2010-05-13

Vaccination Regimen for B-Cell Vaccines

 #119
20100105672
2010-04-29

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #120
20100068222
2010-03-18

Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same

 #121
20100015172
2010-01-21

Method to reduce the physiologic effects of drugs on mammals

 #122
20090238797
2009-09-24

NICOTINE-CARRIER VACCINE FORMULATION

 #123
20090196886
2009-08-06

VACCINE AGAINST NICOTINE ADDICTION

 #124
20080241183
2008-10-02

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

 #125
20080095738
2008-04-24

VLP-antigen conjugates and their uses as vaccines

 #126
20080063660
2008-03-13

Method to reduce the physiologic effects of drugs on mammals

 #127
20080038291
2008-02-14

Method to reduce the physiologic effects of drugs on mammals

 #128
20080026000
2008-01-31

Hapten-carrier conjugates for treating and preventing nicotine addiction

 #129
20070224209
2007-09-27

Therapeutic uses of glandular kallikrein

 #130
20070212364
2007-09-13

Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

 #131
20070087409
2007-04-19

Angiotensin peptide-carrier conjugates and uses thereof

 #132
20060286099
2006-12-21

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #133
20060286098
2006-12-21

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #134
20060286097
2006-12-21

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #135
20060286096
2006-12-21

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #136
20060286095
2006-12-21

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #137
20060286094
2006-12-21

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #138
20060280736
2006-12-14

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #139
20060280735
2006-12-14

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #140
20060239997
2006-10-26

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #141
20060078554
2006-04-13

Angiotensin peptide-carrier conjugates and uses thereof

 #142
20060058220
2006-03-16

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #143
20050281845
2005-12-22

Hapten-carrier conjugates and uses thereof

 #144
20050136047
2005-06-23

Hapten-carrier conjugates for treating and preventing nicotine addiction

 #145
20050124061
2005-06-09

Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same

 #146
20050100901
2005-05-12

Vaccine for treating nicotine addiction

 #147
20050089524
2005-04-28

Compositions and compounds for use as molecular adjuvant for a nicotine vaccine

 #148
20050026303
2005-02-03

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates